
AxoGen
Developing technologies for peripheral nerve regeneration and repair.
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor | €0.0 | round |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
* | N/A | $41.0m | Post IPO Equity |
Total Funding | 000k |

Essex Woodlands Health Ventures(exited)

Cardinal Partners(exited)

Accuitive Medical Ventures(exited)

DeNovo Ventures(exited)

Springboard Capital(exited)

EW Healthcare Partners(exited)

ATEL Ventures(exited)

Emory University(exited)

JAM Capital Partners(exited)

PDL Biopharma(exited)

Armentum Partners(exited)
USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 13 % | 9 % | 15 % | 18 % | 15 % | 16 % | 17 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (16 %) | (18 %) | (10 %) | 2 % | 11 % | 16 % | 24 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (21 %) | (21 %) | (14 %) | (5 %) | (2 %) | 5 % | 9 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 19 % | 20 % | 18 % | 15 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.